CCCC (C4 Therapeutics, Inc.) Earnings growth in current year

Official company branding of c4therapeutics.com (CCCC)

C4 Therapeutics, Inc. (CCCC) is currently in the clinical trial stage, where fixed R&D costs preclude margin growth. The annual EPS range demonstrates local dynamics, with the 39.70 mark reflecting the latest data. The business relies on outsourcing molecule development to minimize capex; however, drug toxicity and dependence on external funding create significant risks to stability.

CCCC (C4 Therapeutics) Earnings growth in current year history from 07/04/2022 to 11/16/2026

Comprehensive metric breakdowns and analytics for C4 Therapeutics, Inc. (CCCC)

- share price and expert price forecast:
Fundamental valuation:CCCC C4 Tx
Signature product of C4 Therapeutics Corp

This metric measures the annual dynamics of net profit per share, determining the pace of business capitalization and the efficiency of resource allocation. By analyzing the EPS comparison with the same period last year on GURU.Markets, an investor sees the value 39.70, which for C4 Therapeutics, Inc. (CCCC) reflects financial stability amid the development of the TORPEDO platform and the race for leadership in the protein degradation segment.

Direct competitors

GMAB: Net earnings per one share growth for the current year|EXEL (Exelixis Inc.) - Earnings growth in current year|Earnings growth in current year nuvalent.com|Earnings per share growth in current year Kymera (KYMR)|IDYA (IDEAYA Biosciences, Inc.) - Earnings per share increase in current year|Earnings growth in current year ELVN (Enliven Therapeutics Inc)|Net earnings per share change in current year ORIC Pharma|Relay Therapeutics Inc - Earnings growth in current year|Earnings per share growth rate in current year Nurix Therapeutics, Inc.|TYRA (Tyra Biosciences, Inc.) - Net earnings per share growth this year|VSTM: Net earnings per one share growth for the current year|GLUE (monterosatx.com) - Earnings growth in current year|Earnings per share growth rate in current year Cullinan Therapeutics Inc CGEM|Earnings growth in current year IMRX|Black Diamond Therapeutics - Earnings per share growth this year|Repare Therapeutics Inc. - Net earnings per share growth this year|Earnings per share increase in current year PMVP|KPTI: Net earnings per share growth this year|propanc.com - Net earnings per one share growth for the current year|BGMS: Earnings growth in current year|Aadi Bioscience Inc - Earnings per share increase in current year|ALRN (Aileron Therapeutics Inc) - Earnings growth in current year|Earnings per share growth rate in current year blueprintmedicines.com BPMC|Earnings per share growth in current year GlycoMimetics Inc. (GLYC)|SWTX (SpringWorks) - Earnings per share increase in current year